Skip to main content
SpringerLink
Log in

Systemic Lupus Erythematosus

  • Chapter
  • First Online:
A Clinician's Pearls & Myths in Rheumatology

  • 1587 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abeles AM, Abeles M. The clinical utility of a positive antinuclear antibody test result. Am J Med. 2013;126(4):342–8.

    PubMed  Google Scholar 

  • Abu-Shakra M, Zalmanson S, Neumann L, Flusser D, Sukenik S, Buskila D. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity. J Rheumatol. 2000;27(7):1681–5.

    CAS  PubMed  Google Scholar 

  • ACR ad hoc committee on neuropsychiatric lupus. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum. 1999;42:599–608.

    Google Scholar 

  • Adler M, Chambers S, Edwards C, Neild G, Isenberg D. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology. 2006;45:1144–7.

    CAS  PubMed  Google Scholar 

  • Aguilera P, Mascaró JM Jr, Martinez A, et al. Cutaneous gamma/delta T-cell lymphoma: a histopathologic mimicker of lupus erythematosusprofundus (lupus panniculitis). J Am Acad Dermatol. 2007;56:643–7.

    PubMed  Google Scholar 

  • Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001;57(3):496–500.

    CAS  PubMed  Google Scholar 

  • Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2020;13:annrheumdis-2020-218946.

    Google Scholar 

  • Akkasilpa S, Goldman D, Magder LS, Petri M. Number of fibromyalgia tender points is associated with health status in patients with systemic lupus erythematosus. J Rheumatol. 2005;32(1):48–50.

    PubMed  Google Scholar 

  • Almebayadh M, Regnier-Rosencher E, Carlotti A, Goulvestre C, Le Guern V, Mouthon L, Avril MF, Dupin N. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors. Dermatology. 2013;226(2):119–23.

    CAS  PubMed  Google Scholar 

  • Alvarado AS, Malvar A, Lococo B, et al. The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients. Lupus. 2014;23:840–7.

    CAS  PubMed  Google Scholar 

  • Alves MR, Isenberg DA. “Mixed connective tissue disease”: a condition in search of an identity. Clin Exp Med. 2020;20(2):159–66.

    PubMed  PubMed Central  Google Scholar 

  • Anderson JJ, Kruszka B, Delaney JA, et al. Calcium intake from diet and supplements and the risk of coronary artery calcification and its progression among older adults: 10-year follow-up of the multi-ethnic study of atherosclerosis (MESA). J Am Heart Assoc. 2016;5(10):e003815.

    PubMed  PubMed Central  Google Scholar 

  • Andreoli L, Piantoni S, Dall’Ara M, et al. Vitamin D and antiphospholipid syndrome. Lupus. 2012;21(7):736–40.

    CAS  PubMed  Google Scholar 

  • Andreoli L, Crisafulli F, Tincani A. Pregnancy and reproductive aspects of systemic lupus erythematosus. Curr Opin Rheumatol. 2017;29(5):473–9. https://doi.org/10.1097/BOR.0000000000000415. PMID: 28678065.

  • Appel GB, Contreras G, Dooley MA, et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol. 2009;20(5):1103–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Aringer M, Graninger WB, Steiner G, Smolen JS. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum. 2004;50(10):3161–9.

    CAS  PubMed  Google Scholar 

  • Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019a;78(9):1151–9.

    PubMed  Google Scholar 

  • Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019b;71(9):1400–12.

    PubMed  PubMed Central  Google Scholar 

  • Aringer M, et al. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis. 2021;80(6):775–81.

    CAS  PubMed  Google Scholar 

  • Baca V, Lavalle C, Garcia R, et al. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol. 1999;26:432–9.

    CAS  PubMed  Google Scholar 

  • Barr S, Zonana-Nacach A, Magder L, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1999;42:2682–8.

    CAS  PubMed  Google Scholar 

  • Bernatsky S, Ramsey-Goldman R, Joseph L, et al. Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann Rheum Dis. 2014;73(1):138–42.

    CAS  PubMed  Google Scholar 

  • Bijl M, Kallenberg CG. Ultraviolet light and cutaneous lupus. Lupus. 2006;15(11):724–7.

    CAS  PubMed  Google Scholar 

  • Black C, Isenberg DA. Mixed connective tissue disease--goodbye to all that. Br J Rheumatol. 1992;31(10):695–700.

    CAS  PubMed  Google Scholar 

  • Boddaert J, Huong D, Zahir A, et al. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine. 2004;83:348–59.

    PubMed  Google Scholar 

  • Bombardier C, Gladman DD, Urowitz M, et al. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 1992;35:630–40.

    CAS  PubMed  Google Scholar 

  • Boumpas D, Yamada H, Patronas N, Scott D, Klippel J, Balow J. Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med. 1991;81:975–84.

    CAS  PubMed  Google Scholar 

  • Boyarsky BJ, Ruddy JA, Connolly CM, et al. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021;23:annrheumdis-2021-220289.

    Google Scholar 

  • Bruce I, Gladmann D, Urowitz M. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient non-adherence. Arthritis Care Res. 2000;13:406–8.

    CAS  PubMed  Google Scholar 

  • Buyon J, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005;142:953–62.

    CAS  PubMed  Google Scholar 

  • Callen JP. Cutaneous lupus erythematosus: a personal approach to management. Australas J Dermatol. 2006;47(1):13–27.

    PubMed  Google Scholar 

  • Calvo-Alen J, Alarcon GS, Burgard SL, et al. Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors. J Rheumatol. 1996;23:469–75.

    CAS  PubMed  Google Scholar 

  • Carvalho MR, Sato EI, Tebexreni AS, et al. Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;53(6):838–44.

    PubMed  Google Scholar 

  • Catalina MD, Bachali P, Geraci NS, et al. Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus. Comm Biol. 2019;2:140.

    Google Scholar 

  • Catalina MD, Bachali P, Yeo AE, et al. Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus. JCI. Insight. 2020;5(15):e140380.

    Google Scholar 

  • Cervera R, Khamashta M, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine. 1993;72:113–24.

    CAS  PubMed  Google Scholar 

  • Chambers S, Charman S, Rahman A, Isenberg D. Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality. Ann Rheum Dis. 2007;66:1173–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chan TM, Li FK, Tang CS, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med. 2000;343(16):1156–62.

    CAS  PubMed  Google Scholar 

  • Chan MT, Owen P, Dunphy J, et al. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol. 2008;35(1):77–83.

    PubMed  Google Scholar 

  • Chang A, Clark MR, Ko K. Cellular aspects of the pathogenesis of lupus nephritis. Curr Opin Rheumatol. 2021;33(2):197–204.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chen TK, Estrella MM, Fine DM. Predictors of kidney biopsy complication among patients with systemic lupus erythematosus. Lupus. 2012 Jul;21(8):848–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cheung KL, Lafayette RA. Renal physiology of pregnancy. Adv Chronic Kidney Dis. 2013;20(3):209–14.

    PubMed  PubMed Central  Google Scholar 

  • Choi MY, Clarke AE, St Pierre Y, et al. Antinuclear antibody-negative systemic lupus erythematosus in an international inception cohort. Arthritis Care Res (Hoboken). 2019;71(7):893–902.

    CAS  PubMed  Google Scholar 

  • Choi MY, FitzPatrick RD, Buhler K, et al. A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus. Autoimmun Rev. 2020;19(3):102463.

    CAS  PubMed  Google Scholar 

  • Christopher-Stine L, Siedner M, Lin H, Haas M, Parekh H, Petri M, et al. Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol. 2007;34:332–5.

    PubMed  Google Scholar 

  • Chrysostomou A, Becker G. Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. N Engl J Med. 2001;345(12):925–6.

    CAS  PubMed  Google Scholar 

  • Clauw DJ. Fibromyalgia: an overview. Am J Med. 2009;122(12 Suppl):S3–S13.

    PubMed  Google Scholar 

  • Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547–55.

    PubMed  Google Scholar 

  • Conrad K, Rober N, Andrade LE, Mahler M. The clinical relevance of anti-DFS70 autoantibodies. Clin Rev Allergy Immunol. 2017;52(2):202–16.

    CAS  PubMed  Google Scholar 

  • Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O’Nan P, et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med. 2004;350(10):971–80.

    CAS  PubMed  Google Scholar 

  • Cooper M, et al. Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing. Transplant Rev (Orlando). 2012;26(4):233–40.

    PubMed  Google Scholar 

  • Costallat L, Coimbra A. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol. 1994;12:603–7.

    CAS  PubMed  Google Scholar 

  • Crowe SR, Merrill JT, Vista ES, et al. Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum. 2011;63(8):2396–406.

    PubMed  PubMed Central  Google Scholar 

  • Cui HW, Lei RY, Zhang SG, Han LS, Zhang BA. Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study. Lupus. 2019;28(8):961–9.

    PubMed  Google Scholar 

  • Cusack C, Danby C, Fallon JC, et al. Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed. 2008;24(5):260–7.

    PubMed  Google Scholar 

  • Cushman M, Kuller LH, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA. 2004;292(13):1573–80.

    CAS  PubMed  Google Scholar 

  • Custodio-Alves S, Fasano S, Isenberg DA. Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case reviews and literature review. Lupus. 2016;25:1509–19.

    Google Scholar 

  • Dale RC, Brilot F, Duffy LV, et al. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology. 2014;83(2):142–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Dall’Era M, Cisternas MG, Smilek DE, et al. Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort. Arthritis Rheumatol. 2015;67(5):1305–13.

    PubMed  Google Scholar 

  • Damian-Abrego G, Cabiedes J, Cabral A. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Lupus. 2008;17:300–4.

    CAS  PubMed  Google Scholar 

  • Damoiseaux J, Andrade LEC, Carballo OG, et al. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Ann Rheum Dis. 2019;78(7):879–89.

    CAS  PubMed  Google Scholar 

  • Danowski A, Magder L, Petri M. Flares in lupus: Outcome Assessment Trial (FLOAT), a comparison between oral methylprednisolone and intramuscular triamcinolone. J Rheumatol. 2006;33(1):57–60.

    CAS  PubMed  Google Scholar 

  • Danza A, Ruiz-Irastorza G. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus. 2013;22(12):1286–94.

    CAS  PubMed  Google Scholar 

  • Daugas E, Nochy D, Huong DLT, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol. 2002;13:42–52.

    PubMed  Google Scholar 

  • De Rosa M, Azzato F, Toblli JE, et al. A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy. Kidney Int. 2018;94(4):788–94.

    PubMed  Google Scholar 

  • De Rosa M, Rocha AS, De Rosa G, et al. Low-grade proteinuria does not exclude significant kidney injury in lupus nephritis. Kidney Int Rep. 2020;13:1066–8.

    Google Scholar 

  • Domenech I, Aydintug O, Cervera R, et al. Systemic lupus erythematosus in 50 year olds. Postgrad Med J. 1992;68:440–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Dooley MA, Jayne D, Ginzler EM, et al. ALMS Group. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med. 2011;365(20):1886–95.

    CAS  PubMed  Google Scholar 

  • Dörner T, Lipsky PE. Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE. Nat Rev Rheumatol. 2016;12(11):645–57.

    PubMed  Google Scholar 

  • Dreyer L, Jacobsen S, Juul L, Terslev L. Ultrasonographic abnormalities and inter-reader reliability in Danish patients with systemic lupus erythematosus - a comparison with clinical examination of wrist and metacarpophalangeal joints. Lupus. 2015;24(7):712–9.

    CAS  PubMed  Google Scholar 

  • Duarte-García A, Barr E, Magder LS, Petri M. Predictors of incident proteinuria among patients with SLE. Lupus Sci Med. 2017;4(1):e000200. https://doi.org/10.1136/lupus-2016-000200.

    Article  PubMed  PubMed Central  Google Scholar 

  • Durcan R, Fu W, Petri M. Oral ulcers in systemic lupus erythematosus: characterization and clarification of an important clinical manifestation [abstract] Arthritis Rheumatol 2015a;67:(suppl 10).

    Google Scholar 

  • Durcan L, Clarke WA, Magder LS, Petri M. Hydroxychloroquine blood levels in systemic lupus erythematosus: clarifying dosing controversies and improving adherence. J Rheumatol. 2015b;42(11):2092–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Elfving P, Kariniemi S, Kautiainen H, et al. Mortality in SLE patients compared to population controls in Finland in years 2000-2015. Rheumatology (Oxford). 2021;60(9):4238–44.

    PubMed  Google Scholar 

  • Elkayam O, Paran D, Caspi D, et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis. 2002;34:147–53.

    PubMed  Google Scholar 

  • Elkayam O, Paran D, Burke M, et al. Pneumococcal vaccination of patients with systemic lupus erythematosus: effects on generation of autoantibodies. Autoimmunity. 2005;38:493–6.

    CAS  PubMed  Google Scholar 

  • Elkayam O et al. Update of EULAR recommendations for vaccination of patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2018;77.

    Google Scholar 

  • Enocsson H, Sjowall C, Skogh T, et al. Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares? Arthritis Rheum. 2009;60:3755–60.

    CAS  PubMed  Google Scholar 

  • Enocsson H, Gullstrand B, Eloranta ML, et al. C-reactive protein levels in systemic lupus erythematosus are modulated by the interferon gene signature and CRP gene polymorphism rs1205. Front Immunol. 2020;11:622326.

    CAS  PubMed  Google Scholar 

  • Erkan D, Harrison MJ, Levy R, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007;56(7):2382–91.

    CAS  PubMed  Google Scholar 

  • Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44(10):2331–7.

    CAS  PubMed  Google Scholar 

  • Espírito Santo J, Gomes MF, Gomes MJ, et al. Intravenous immunoglobulin in lupus panniculitis. Clin Rev Allergy Immunol. 2010;38(2–3):307–18.

    PubMed  Google Scholar 

  • Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–45.

    CAS  PubMed  Google Scholar 

  • Fanouriakis A, Kostopoulou M, Cheema K, et al. Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2020;79:713–23.

    CAS  PubMed  Google Scholar 

  • Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol. 2006;33:1563–9.

    PubMed  Google Scholar 

  • Fei Y, Shi X, Gan F, et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol. 2014;33(1):57–63.

    PubMed  Google Scholar 

  • Feldmann R, Salomon D, Saurat JH. The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus. Dermatology. 1994;189(4):425–7.

    CAS  PubMed  Google Scholar 

  • Fernandez M, Calvo-Alen J, Bertoli A, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women. J Clin Rheumatol. 2007;13:261–5.

    PubMed  Google Scholar 

  • Fernandez-Nebro A, Palacios-Munoz R, Gordillo J, Abarca-Costalago M, De Haro-Liger M, Rodriguez-Andreu J, et al. Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study. Lupus. 1999;8(2):151–6.

    CAS  PubMed  Google Scholar 

  • Fessler B. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol. 2002;16:281–91.

    PubMed  Google Scholar 

  • Fessler BJ, Alarcon GS, McGwin G Jr, et al. Systemic lupus erythematosus in three ethnic groups: association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum. 2005;52(5):1473–80.

    PubMed  Google Scholar 

  • Fitzcharles MA, Ste-Marie PA, Goldenberg DL, et al. 2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2012;18(3):119–26.

    Google Scholar 

  • Font J, Pallares L, Cervera R, et al. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis. 1991;50:702–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Foote R, Kimbrough S, Stevens J. Lupus myositis. Muscle Nerve. 1982;5:65–8.

    CAS  PubMed  Google Scholar 

  • Formiga F, Moga I, Pac M, et al. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. Lupus. 1999;8:462–5.

    CAS  PubMed  Google Scholar 

  • Furie R, Petri M, Zamani O, et al. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 2011;63:3918–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Furie R, Rovin BH, Houssiau F, et al. Two-year, randomized, controlled trial of belimumab in lupus nephritis. N Engl J Med. 2020;383(12):1117–28.

    CAS  PubMed  Google Scholar 

  • Fusconi M, Vannini A, Dall’aglio AC, Pappas G, Bianchi FB, Zauli D. Etanercept and infliximab induce the same serological autoimmune modifications in patients with rheumatoid arthritis. Rheumatol Int. 2007;28(1):47–9.

    CAS  PubMed  Google Scholar 

  • Gammon B, Hansen C, Costner MI. Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus. J Am Acad Dermatol. 2011 Oct;65(4):717–721.e2.

    CAS  PubMed  Google Scholar 

  • Ganczarczyk L, Urowitz MB, Gladman DD. Latent lupus. J Rheumatol. 1989;16:475–8.

    CAS  PubMed  Google Scholar 

  • Gatla N, Annapureddy N, Sequeira W, Jolly M. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol. 2013;19(6):334–40.

    PubMed  Google Scholar 

  • Geraminejad P, Stone MS, Sontheimer RD. Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus. Lupus. 2004;13:473–7.

    CAS  PubMed  Google Scholar 

  • Gianfrancesco M, Hyrich KL, Al-Adely S, et al. COVID-19 Global Rheumatology Alliance. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79(7):859–66.

    CAS  PubMed  Google Scholar 

  • Gilland WR, Tsokos GC. Prophylactic use of antibiotics and immunisations in patients with SLE. Ann Rheum Dis. 2002;61(3):191–2.

    Google Scholar 

  • Gilliam JN, Cheatum DE, Hurd ER, et al. Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease. J Clin Invest. 1974;53(5):1434–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ginsburg KS, Liang MH, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med. 1992;117:997–1002.

    CAS  PubMed  Google Scholar 

  • Ginzler EM, Dooley MA, Aranow C, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med. 2005;353(21):2219–28.

    CAS  PubMed  Google Scholar 

  • Gladman D, Hussain F, Ibanez D, Urowitz M. The nature and outcome of infection in systemic lupus erythematosus. Lupus. 2002;11:234–9.

    CAS  PubMed  Google Scholar 

  • Godeau B, Coutant-Perronne V, Le Thi Huong D, et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol. 1994;21(2):246–51.

    CAS  PubMed  Google Scholar 

  • Gorbachev AV, Gasparian AV, Gurova KV, et al. Quinacrine inhibits the epidermal dendritic cell migration initiating T cell-mediated skin inflammation. Eur J Immunol. 2007;37(8):2257–67.

    CAS  PubMed  Google Scholar 

  • Graninger D, Smolen JS. Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology (Oxford). 2001;40:89–94.

    PubMed  Google Scholar 

  • Guthridge CJ, Gross T, Quintero M, et al. Expanded autoantibody profiles for subsetting of native American, African American, and European american patients with systemic lupus erythematosus. ACR Open Rheumatol. 2020;2(7):415–23.

    PubMed  PubMed Central  Google Scholar 

  • Hahn BH, Yardley JH, Stevens MB. “Rheumatoid” nodules in systemic lupus erythematosus. Ann Intern Med. 1970;72(1):49–58.

    CAS  PubMed  Google Scholar 

  • Hanly JG, Li Q, Su L, et al. Psychosis in systemic lupus erythematosus: results from an international inception cohort study. Arthritis Rheumatol. 2019;71(2):281–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436–46.

    CAS  PubMed  Google Scholar 

  • Hesselink D, Aarden L, Swaak A. Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus. Scand J Rheumatol. 2003;32:151–5.

    CAS  PubMed  Google Scholar 

  • Hill DD, Eudy AM, Egger PJ, et al. Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre. Lupus Sci Med. 2021;8(1):e000446.

    PubMed  PubMed Central  Google Scholar 

  • Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494–500.

    CAS  PubMed  Google Scholar 

  • Ho C, Mok C, Lau C, Wong R. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis. 1998;57:437–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ho A, Magder L, Barr S, Petri M. Decreases in anti-double stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum. 2001a;44:2342–9.

    CAS  PubMed  Google Scholar 

  • Ho A, Magder LS, Barr SG, Petri MA. A decrease in complement is associated with increased renal and hematologic flares in patients with systemic lupus erythematosus. Arthritis Rheum. 2001b;44:2350–7.

    CAS  PubMed  Google Scholar 

  • Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum. 1997;40:1725.

    CAS  PubMed  Google Scholar 

  • Huong DL, Papo T, Beaufuls H, Wechsler B. Renal involvement in systemic lupus erythematosus: a study of 180 patients from a single center. Medicine (Baltimore). 1999;78:148.

    CAS  PubMed  Google Scholar 

  • Hussein S, Suitner M, Beland-Bonenfant S, et al. Monitoring of osteonecrosis in systemic lupus erythematosus: a systemic review and meta-analysis. J Rheumatol. 2018;45(10):1462–76.

    CAS  PubMed  Google Scholar 

  • Iaboni A, Ibanez D, Gladman DD, et al. Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression. J Rheumatol. 2006;33(12):2453–7.

    PubMed  Google Scholar 

  • Iagnocco A, Ceccarelli F, Rizzo C, et al. Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus. Rheumatology (Oxford). 2014;53(3):465–72.

    PubMed  Google Scholar 

  • Iliopoulos A, Tsokos G. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum. 1996;25:318–36.

    CAS  PubMed  Google Scholar 

  • Irving KS, Sen D, Tahir H, et al. A comparison of autoimmune liver disease in juvenile and adult populations with systemic lupus erythematosus-a retrospective review of cases. Rheumatology (Oxford). 2007;46(7):1171–3.

    CAS  PubMed  Google Scholar 

  • Isenberg D, Horsfall A. Systemic lupus erythematosus-adult onset. In: Maddison P, Isenberg D, Woo P, Glass D, editors. Oxford textbook of rheumatology. Oxford University Press; 1998. p. 1145–80.

    Google Scholar 

  • Jewell ML, McCauliffe DP. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol. 2000;42(6):983–7.

    CAS  PubMed  Google Scholar 

  • Jonsdottir T, Forslid J, van Vollenhoven R, et al. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies. Ann Rheum Dis. 2004;63(9):1075–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Jorge A, Wallace ZS, Lu N, Zhang Y, Choi HK. Renal transplantation and survival among patients with lupus nephritis: a cohort study. Ann Intern Med. 2019;170:240–7.

    PubMed  PubMed Central  Google Scholar 

  • Jorizzo JL, Salisbury PL, Rogers RS 3rd, et al. Oral lesions in systemic lupus erythematosus. Do ulcerative lesions represent a necrotizing vasculitis? J Am Acad Dermatol. 1992;27(3):389–94.

    CAS  PubMed  Google Scholar 

  • Kalia S, Dutz JP. New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther. 2007;20(4):160–74.

    PubMed  PubMed Central  Google Scholar 

  • Kallas R, Li J, Petri M. Predictors of osteonecrosis in systemic lupus erythematosus: a prospective cohort study. Arthritis Care Res (Hoboken). 2022;74(7):1122–32.

    CAS  PubMed  Google Scholar 

  • Karpatkin S. Autoimmune thrombocytopaenic purpura. Semin Haematol. 1985;22:260–88.

    CAS  Google Scholar 

  • Kasitanon N, Fine DM, Haas M, et al. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis. Lupus. 2006;15(6):366–70.

    CAS  PubMed  Google Scholar 

  • Klippel JH, Karsh J, Stahl NI, et al. A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum. 1979;22:1321–5.

    CAS  PubMed  Google Scholar 

  • Koneru S, Shishov M, Ware A, et al. Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum. 2007;57(6):1000–6.

    PubMed  Google Scholar 

  • Konig MF, Gianfrancesco M, Yazdany J, et al. Response to: ‘clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Carbillon et al. Ann Rheum Dis. 2021;80:e55.

    CAS  PubMed  Google Scholar 

  • Koopman MG, Krediet RT, Zuyderhoudt FJ, et al. A circadian rhythm of proteinuria in patients with a nephrotic syndrome. Clin Sci. 1985;69:395–401.

    CAS  Google Scholar 

  • Lalani S, Pope J, de Leon F, et al. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from 1000 faces of lupus study. J Rheumatol. 2010;37:38–44.

    PubMed  Google Scholar 

  • Li R, Mitchell P, Dowling R, et al. Is hypertension predictive of clinical recurrence in posterior reversible encephalopathy syndrome? J Clin Neurosci. 2013;20(2):248–52.

    PubMed  Google Scholar 

  • Li D, Radulescu A, Shrestha RT, et al. Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults. JAMA. 2017;318(12):1150–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lins CF, Santiago MB. Ultrasound evaluation of joints in systemic lupus erythematosus: a systemic review. Eur Radiol. 2015;25:2688–92.

    PubMed  Google Scholar 

  • Mackay IR, et al. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet. 1959;1:65.

    CAS  PubMed  Google Scholar 

  • Magder LS, Petri M. Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol. 2012;176(8):708–19.

    PubMed  PubMed Central  Google Scholar 

  • Mahler M, Andrade LE, Casiano CA, et al. Anti-DFS70 antibodies: an update on our current understanding and their clinical usefulness. Expert Rev Clin Immunol. 2019;15(3):241–50.

    CAS  PubMed  Google Scholar 

  • Mahmoud K, et al. Ultrasound to identify SLE patients with musculoskeletal symptoms who respond best to therapy: the USEFUL longitudinal multicentre study. Rheumatology (Oxford). 2021;60(11):5194–204.

    CAS  PubMed  Google Scholar 

  • Malvar A, Alberton V, Lococo B, et al. Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis. Kidney Int. 2020;97:156–62.

    CAS  PubMed  Google Scholar 

  • Manoussakis M, Georgopoulou C, Zintzaras E, et al. Sjogren’s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren’s syndrome. Arthritis Rheum. 2004;50:882–91.

    PubMed  Google Scholar 

  • Marmor MF, Kellner U, Lai TY, et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123(6):1386–94.

    PubMed  Google Scholar 

  • Masamoto M, et al. Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation. Ther Drug Monit. 2008;30(1):46–51.

    Google Scholar 

  • Matar HE, Peterson P, Sangle S, D’Cruz DP. Correlation of 24-hour urinary protein quantification with spot urine protein: creatinine ratio in lupus nephritis. Lupus. 2012;21(8):836–9.

    CAS  PubMed  Google Scholar 

  • McDonagh J, Isenberg D. Development of additional autoimmune disease in a population of patients with systemic lupus erythematosus. Ann Rheum Dis. 2000;59:230–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132(12):1453–60.

    PubMed  Google Scholar 

  • Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis. 2010;69:1420–2.

    CAS  PubMed  Google Scholar 

  • Merrill JT, Neuwelt CM, Wallace DJ, et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010;62(1):222–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Middleton GD, McFarlin JE, Lipsky PE. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum. 1994;37(8):1181–8.

    CAS  PubMed  Google Scholar 

  • Miot HA, Bartoli Miot LD, Haddad GR. Association between discoid lupus erythematosus and cigarette smoking. Dermatology. 2005;211(2):118–22.

    PubMed  Google Scholar 

  • Modi GM, Maender JL, Coleman N, et al. Tinea corporis masquerading as subacutecutaneous lupus erythematosus. Dermatol Online J. 2008;14(4):8.

    PubMed  Google Scholar 

  • Mok C. Prognostic factors in lupus nephritis. Lupus. 2005;14:39–44.

    CAS  PubMed  Google Scholar 

  • Mok CC. Vitamin D and systemic lupus erythematosus: an update. Expert Rev Clin Immunol. 2013;9(5):453–63.

    CAS  PubMed  Google Scholar 

  • Moroni G, Doria A, Giglio E, et al. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. J Autoimmun. 2016;74:194–200.

    PubMed  Google Scholar 

  • Mosca M, et al. Brief report: how do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new classification criteria. Arthritis Rheumatol. 2019;71(1):91–8.

    PubMed  Google Scholar 

  • Naveed A, Nilubol C, Melancon JK, et al. Preemptive kidney transplantation in systemic lupus erythematosus. Transplant Proc. 2011;43:3713–4.

    CAS  PubMed  Google Scholar 

  • Nehar-Belaid D, Hong S, Marches R, et al. Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol. 2020;21(9):1094–106.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Neuwelt C, Lacks S, Kaye B, et al. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med. 1995;98:32–41.

    CAS  PubMed  Google Scholar 

  • Ng K, Manson J, Rahman A, Isenberg D. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Arthritis Care Res. 2006;55:900–4.

    CAS  Google Scholar 

  • Niiyama S, Katsuoka K, Happle R, et al. Multiple eruptive dermatofibromas: a review of the literature. Acta Derm Venereol. 2002;82(4):241–4.

    PubMed  Google Scholar 

  • Noel V, Lortholary O, Casassus P, et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis. 2001;60:1141–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Oh YJ, Park EH, Park JW, et al. Practical utility of D-dimer test for venous thromboembolism in systemic lupus erythematosus depends on disease activity: a retrospective cohort study. J Korean Med Sci. 2020;35(43):e356.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Omdal R, Mellgren SI, Koldingsnes W, et al. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. J Rheumatol. 2002;29(3):482–6.

    PubMed  Google Scholar 

  • O’Neill S, Isenberg D. Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety. Lupus. 2006;15:778–83.

    PubMed  Google Scholar 

  • Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. J Clin Rheumatol. 2013;19(2):72–7.

    PubMed  Google Scholar 

  • Palines RV, Esfahani F, Baer AN. Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol. 2000;6(4):204–9.

    CAS  PubMed  Google Scholar 

  • Parikh S, Almaani S, Brodsky S, et al. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020;76(2):265–81.

    PubMed  Google Scholar 

  • Pego-Reigosa JM, Isenberg DA. Psychosis due to systemic lupus erythematosus: characteristics and long term outcome of this rare manifestation of the disease. Rheumatology. 2008;47:1498–502.

    CAS  PubMed  Google Scholar 

  • Pengo V, Banzato A, Bison E, et al. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial. Lupus. 2016;25(3):301–6.

    CAS  PubMed  Google Scholar 

  • Perl A, Nagy G, Gergely P, et al. Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol Med. 2004;102:87–114.

    CAS  PubMed  Google Scholar 

  • Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins lupus cohort: an update. Arthritis Care Res. 1995;8:137–45.

    CAS  PubMed  Google Scholar 

  • Petri M. Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective. Scand J Rheumatol. 1996;25:191–3.

    CAS  PubMed  Google Scholar 

  • Petri M. Infection in systemic lupus erythematosus. Rheumatic Dis Clin N Am. 1998;24:423–56.

    CAS  Google Scholar 

  • Petri M. Prospective study of systemic lupus erythematosus pregnancies. Lupus. 2004;13(9):688–9.

    CAS  PubMed  Google Scholar 

  • Petri M, Allbritton J. Antibiotic allergy in systemic lupus erythematosus: a case-control study. J Rheumatol. 1992;19(2):265–9.

    CAS  PubMed  Google Scholar 

  • Petri M, Genovese M, Engle E, et al. Definition, incidence and clinical description of flare in systemic lupus erythematosus: a prospective cohort study. Arthritis Rheum. 1991a;34:937–44.

    CAS  PubMed  Google Scholar 

  • Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 1991b;34(12):1538–45:265–9.

    CAS  PubMed  Google Scholar 

  • Petri M, Perez-Gutthann S, Longenecker J, et al. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med. 1991c;91:345–53.

    CAS  PubMed  Google Scholar 

  • Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2550–8.

    CAS  PubMed  Google Scholar 

  • Petri MA, Kiani AN, Post W, et al. Lupus atherosclerosis prevention study (LAPS). Ann Rheum Dis. 2011;70(5):760–5.

    CAS  PubMed  Google Scholar 

  • Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012a;64(8):2677–86.

    PubMed  PubMed Central  Google Scholar 

  • Petri M, Bello KJ, Fang H, Magder LS. Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum. 2013;65(7):1865–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Petri M, Elkhalifa M, Li J, et al. Hydroxychloroquine blood levels predict hydroxychloroquine retinopathy. Arthritis Rheum. 2020;72(3):448–53.

    CAS  Google Scholar 

  • Petri M, Konig MF, Li J, Goldman DW. Higher hydroxychloroquine blood levels are associated with reduced thrombosis risk in systemic lupus erythematosus. Arthritis Rheumatol. 2021;73:997–1004.

    Google Scholar 

  • Petri M, Barr E, Magder LS. Risk of renal failure within 10 or 20 years of systemic lupus erythematosus diagnosis. J Rheumatol. 2021a;48(2):222–7.

    PubMed  Google Scholar 

  • Petri M, Goldman DW, Alarcón GS, et al. A comparison of 2019 EULAR/ACR SLE classification criteria with two sets of earlier SLE classification criteria. Arthritis Care Res (Hoboken). 2021b;73(9):1231–5.

    PubMed  Google Scholar 

  • Piantoni S, Andreoli L, Allegri F, et al. Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease. Reumatismo. 2012;64(5):307–13.

    CAS  PubMed  Google Scholar 

  • Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003;139(8):683–93.

    CAS  PubMed  Google Scholar 

  • Pierangeli SS, Harris EN. In vivo models of thrombosis for the antiphospholipid syndrome. Lupus. 1996;5(5):451–5.

    CAS  PubMed  Google Scholar 

  • Pisetsky DS, Lipsky PE. New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol. 2020;16(10):565–79.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Pisetsky DS, Rovin BH, Lipsky PE. New Perspectives in Rheumatology: biomarkers as entry criteria for clinical trials of new therapies for systemic lupus erythematosus: the example of antinuclear antibodies and anti-DNA. Arthritis Rheumatol. 2017;69:487–93.

    PubMed  Google Scholar 

  • Pisetsky DS, Spencer DM, Lipsky PE, et al. Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE. Ann Rheum Dis. 2018;77(6):911–3.

    CAS  PubMed  Google Scholar 

  • Pisetsky DS, Thompson DK, Wajdula J, et al. Variability in antinuclear antibody testing to assess patient eligibility for clinical trials of novel treatments for systemic lupus erythematosus. Arthritis Rheumatol. 2019a;71(9):1534–8.

    CAS  PubMed  Google Scholar 

  • Pisetsky DS, Bossuyt X, Meroni PL. ANA as an entry criterion for the classification of SLE. Autoimmun Rev. 2019b;18(12):102400.

    CAS  PubMed  Google Scholar 

  • Pisetsky DS, Clowse MEB, Criscione-Schreiber LG, et al. A novel system to categorize the symptoms of systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2019c;71(6):735–41.

    PubMed  Google Scholar 

  • Plantinga LC, Patzer RE, Drenkard C, et al. Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis. Arthritis Care Res. 2015;67:571–81.

    Google Scholar 

  • Provost TT, Andres G, Maddison PJ, Reichlin M. Lupus band test in untreated SLE patients: correlation of immunoglobulin deposition in the skin of the extensor forearm with clinical renal disease and serological abnormalities. J Invest Dermatol. 1980;74(6):407–12.

    CAS  PubMed  Google Scholar 

  • Pyne D, Isenberg D. Autoimmune thyroid diseases in systemic lupus erythematosus. Ann Rheum Dis. 2002;61:70–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ramos P, Mendez M, Ames P, et al. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol. 1996;14:295–9.

    CAS  PubMed  Google Scholar 

  • Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349(25):2399–406.

    CAS  PubMed  Google Scholar 

  • Rönnblom L, Leonard D. Interferon pathway in SLE: one key to unlocking the mystery of the disease. Lupus Sci Med. 2019;6(1):e000270.

    PubMed  PubMed Central  Google Scholar 

  • Rovin BH, Teng YKO, Ginzler EM, et al. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2021;397:2070–80.

    CAS  PubMed  Google Scholar 

  • Roy S, Tan K. Pyrexia and normal C-reactive protein (CRP) in patients with systemic lupus erythematosus: always consider the possibility of infection in febrile patients with systemic lupus erythematosus regardless of CRP levels. Rheumatology. 2001;40:349–50.

    CAS  PubMed  Google Scholar 

  • Rubin RL, Joslin FG, Tan EM. Specificity of anti-histone antibodies in systemic lupus erythematosus. Arthritis Rheum. 1982;25(7):779–82.

    CAS  PubMed  Google Scholar 

  • Sandholdt LH, Laurinaviciene R, Bygum A. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2014;170(2):342–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sandhu VK, Wei J, Thomson LEJ, et al. Five-year follow-up of coronary microvascular dysfunction and coronary artery disease in systemic lupus erythematosus: results from a community-based lupus cohort. Arthritis Care Res (Hoboken). 2020;72(7):882–7.

    PubMed  Google Scholar 

  • Sato EI. Methotrexate therapy in systemic lupus erythematosus. Lupus. 2001;10(3):162–4.

    CAS  PubMed  Google Scholar 

  • Scheinfeld N, Deleo VA. Photosensitivity in lupus erythematosus. Photodermatol Photoimmunol Photomed. 2004;20(5):272–9.

    PubMed  Google Scholar 

  • Schmidt E, Bröcker EB, Goebeler M. Rituximab in treatment-resistant autoimmune blistering skin disorders. Clin Rev Allergy Immunol. 2008;34(1):56–64.

    CAS  PubMed  Google Scholar 

  • Shah R, Brodsky SV, Hebert L, et al. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies. Lupus. 2018;27:2236–44.

    CAS  PubMed  Google Scholar 

  • Shidham G, Ayoub I, Birmingham D, et al. Limited reliability of the spot urine protein/creatinine ratio in the longitudinal evaluation of patients with lupus nephritis. Kidney Int Rep. 2018;3:1057–63.

    PubMed  PubMed Central  Google Scholar 

  • Signorelli F, Nogueira F, Domingues V, et al. Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases. Clin Rheumatol. 2016;35(3):801–5.

    PubMed  Google Scholar 

  • Sivaraj RR, Durrani OM, Denniston AK, et al. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford). 2007;46(12):1757–62.

    CAS  PubMed  Google Scholar 

  • Smyth A, Oliveira GH, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5:2060–8.

    PubMed  PubMed Central  Google Scholar 

  • Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol. 2002;29(12):2531–6.

    CAS  PubMed  Google Scholar 

  • Spronk P, ter Borg E, Kallenberg C. Patients with systemic lupus erythematosus and Jaccoud’s arthropathy: a clinical subset with an increased C reactive protein response? Ann Rheum Dis. 1992;51:358–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Stahl NI, Klippel JH, Decker JL. Fever in systemic lupus erythematosus. Am J Med. 1979;67:935–40.

    CAS  PubMed  Google Scholar 

  • Stevens E, Weinblatt ME, Massarotti E, et al. Safety of the zoster vaccine recombinant adjuvanted in rheumatoid arthritis and other systemic rheumatic disease patients: a single center’s experience with 400 patients. ACR Open Rheumatol. 2020;2(6):357–61.

    PubMed  PubMed Central  Google Scholar 

  • Stohl W, Hiepe F, Latinis KM, et al. Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum. 2012;64(7):2328–37.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Stratton MA. Drug-induced systemic lupus erythematosus. Clin Pharm. 1985;4(6):657–63.

    CAS  PubMed  Google Scholar 

  • Takada K, Illei G, Boumpas D. Cyclophosphamide for the treatment of systemic lupus erythematosus. Lupus. 2001;10:154–61.

    CAS  PubMed  Google Scholar 

  • Tam LS, Li EK, Wong CK, et al. Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus. Lupus. 2004;13(8):601–4.

    CAS  PubMed  Google Scholar 

  • Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–7.

    CAS  PubMed  Google Scholar 

  • Tani C, et al. Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience. RMD Open. 2019;5(2):e000916.

    PubMed  PubMed Central  Google Scholar 

  • Taylor J, Skan J, Erb N, et al. Lupus patients with fatigue: is there a link with fibromyalgia syndrome? Rheumatology. 2000;39:620–3.

    CAS  PubMed  Google Scholar 

  • Tedeschi SK, et al. Developing and refining new candidate criteria for systemic lupus erythematosus classification: an international collaboration. Arthritis Care Res (Hoboken). 2018;70(4):571–81.

    CAS  PubMed  Google Scholar 

  • Tench CM, McCarthy J, McCurdie I, et al. Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology (Oxford). 2003;42(9):1050–4.

    CAS  PubMed  Google Scholar 

  • ter Borg EJ, Horst G, Limburg PC, van Rijswijk MH, Kallenberg CG. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol. 1990;17(12):1642–8.

    PubMed  Google Scholar 

  • Thomas G, Mancini J, Jourde-Chiche N, et al. Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis. Arthritis Rheumatol. 2014;66:2503–11.

    PubMed  Google Scholar 

  • Totoritis MC, Tan EM, McNally EM, et al. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. N Engl J Med. 1988;318(22):1431–6.

    CAS  PubMed  Google Scholar 

  • Touma Z, Urowitz MB, Ibañez D, et al. Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment. J Rheumatol. 2014;41(4):688–97. https://doi.org/10.3899/jrheum.130005.

    Article  CAS  PubMed  Google Scholar 

  • Tsakonas E, Joseph L, Esdaile JM, Choquette D, Senecal JL, Cividino A, et al. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus. 1998;7:80–5.

    CAS  PubMed  Google Scholar 

  • Tselios K, Gladman DD, Sheane BJ, Su J, Urowitz M. All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013). Ann Rheum Dis. 2019;78(6):802–6.

    PubMed  Google Scholar 

  • Tsokos GC. Drugs, sun and T cells in lupus. Clin Exp Immunol. 2004;136(2):191–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Turner-Stokes L, Cambridge G, Corcoran T, et al. In vitro response to influenza immunisation by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune disease. Ann Rheum Dis. 1988;47:532–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Tzung TY, Liu YS, Chang HW. Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study. Br J Dermatol. 2007;156(1):191–2.

    CAS  PubMed  Google Scholar 

  • Ueki H. Koebner phenomenon in lupus erythematosus with special consideration of clinical findings. Autoimmun Rev. 2005;4(4):219–23.

    PubMed  Google Scholar 

  • Urowitz MB, Bookman AAM, Koehler BE, et al. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976;60:221–5.

    CAS  PubMed  Google Scholar 

  • Urowitz MB, Ohsfeldt RL, Wielage RC, et al. Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis. ARD. 2019;78(3):372–9.

    CAS  PubMed  Google Scholar 

  • Urowitz MB, Gladman DD, Farewell V, et al. Accrual of atherosclerotic vascular events in a multicenter inception systemic lupus erythematosus cohort. Arthritis Rheumatol. 2020;72(10):1734–40.

    CAS  PubMed  Google Scholar 

  • Urowitz MB, Gladman DD, Ibanez D, et al. Effect of disease activity on organ damage progression in systemic lupus erythematosus: University of Toronto Lupus Clinic Cohort. J Rheumatol. 2021;48(1):67–73.

    CAS  PubMed  Google Scholar 

  • van Vollenhoven RF, Petri MA, Cervera R, Roth DA, Ji BN, Kleoudis CS, Zhong ZJ, Freimuth W. Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response. Ann Rheum Dis. 2012;71(8):1343–9.

    PubMed  Google Scholar 

  • Vassilakopoulos TP, Pangalis GA. Application of a prediction rule to select which patients presenting with lymphadenopathy should undergo a lymph node biopsy. Medicine (Baltimore). 2000;79(5):338–47.

    CAS  PubMed  Google Scholar 

  • Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426–35.

    CAS  PubMed  Google Scholar 

  • Wagner SJ, Craici I, Reed D, et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus. 2009;18:342–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wahl DG, Guillemin F, de Maistre E, Perret C, Lecompte T, Thibaut G. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus: a meta-analysis. Lupus. 1997;6:467–73.

    CAS  PubMed  Google Scholar 

  • Wallace DJ, Stohl W, Furie RA, et al. A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. Arthritis Rheum. 2009;61(9):1168–78.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Walz LeBlanc BAE, Gladman DD, Urowitz MB. Serologically active clinically quiescent systemic lupus erythematosus: predictors of clinical flares. J Rheumatol. 1994;21:2239–41.

    CAS  PubMed  Google Scholar 

  • Ward MM. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982–1995. Arch Intern Med. 2000;160:3136–40.

    CAS  PubMed  Google Scholar 

  • Wells JV, Webb J, Van Deventer M, et al. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases. Clin Exp Immunol. 1979;38(3):424–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Werth VP, Sanchez M, White W, et al. Incidence of alopecia areata in lupus erythematosus. Arch Derm. 1992;128:368–71.

    CAS  PubMed  Google Scholar 

  • Wiik AS, Hoier-Madsen M, Forslid J, et al. Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun. 2010;35(3):276–90.

    CAS  PubMed  Google Scholar 

  • Williams EL, Gadola S, Edwards CJ. Anti-TNF-induced lupus. Rheumatology (Oxford). 2009 Jul;48(7):716–20. https://doi.org/10.1093/rheumatology/kep080.

    Article  CAS  PubMed  Google Scholar 

  • Wilson H, Hamilton M, Spyker D, et al. Age influences the clinical and serologic expression of systemic lupus erythematosus. Arthritis Rheum. 1981;24:1230–5.

    CAS  PubMed  Google Scholar 

  • Woller SC, Stevens SM, Kaplan DA, et al. Apixaban for the secondary prevention of thrombosis among patients with antiphospholipid syndrome: study rationale and design (ASTRO-APS). Clin Appl Thromb Hemost. 2016 Apr;22(3):239–47.

    CAS  PubMed  Google Scholar 

  • Yogasundaram H, Putko BN, Tien J, et al. Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment. Can J Cardiol. 2014;30(12):1706–15.

    PubMed  Google Scholar 

  • Zamorano Martín F, Rocha-de-Lossada C, Rachwani R, et al. Tamoxifen maculopathy: the importance of screening and long follow-up. J Fr Ophtalmol. 2020;43(8):727–30.

    PubMed  Google Scholar 

  • Zandman-Goddard G, Shoenfeld Y. SLE and infections. Clin Rev Allergy Immunol. 2003;25:29–40.

    PubMed  Google Scholar 

  • Zuily S, Cohen H, Isenberg D, et al. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2020;18(9):2126–37.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Michelle Petri

  2. Division of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus, Dresden, Germany

    Michelle Petri

  3. Division of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus, Dresden, Germany

    Martin Aringer

  4. Department of Medicine, Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, USA

    Isabelle Ayoub

  5. Department of Internal Medicine, The Ohio State Wexner Medical Center, Columbus, OH, USA

    Salem Almaani & Brad Rovin

  6. Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA

    Hermine Brunner

  7. School of Medicine, University of California, San Francisco, CA, USA

    Maria Dall’Era

  8. Department of Nephrology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    Mengdi Jiang

  9. Division of Rheumatology, Northwell Health and Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA

    Richard Furie

  10. Department of Internal Medicine, Davis Heart and Lung Research Institute, Ohio State University Medical Center, Columbus, OH, USA

    Jessica Greco

  11. Department of Rheumatology, The Repatriation General Hospital, Adelaide, SA, Australia

    Fiona Goldblatt

  12. Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH, USA

    Jennifer Huggins

  13. Leiden University, Leiden, The Netherlands

    T. W. J. Huizinga

  14. Centre for Rheumatology, Division of Medicine, University College London, London, UK

    David Isenberg

  15. Department of Rheumatology, University College London Hospitals NHS Foundation Trust, London, UK

    David Isenberg

  16. Department of Internal Medicine, Division of Nephrology, The Ohio State University, Columbus, OH, USA

    Nicholas L. Li

  17. Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands

    R. C. Monahan

  18. Division of Nephrology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA

    Samir V. Parikh

  19. Departments of Medicine and Immunology, Duke University Medical Center and Medical Research Service, Veterans Administration Medical Center, Durham, NC, USA

    David Pisetsky

  20. Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Abin P. Puravath

  21. Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Daniel Wallace

  22. Department of Rheumatology, Beijing Hospital, National Center of Gerontology, Beijing, China

    Xuan Zhang

  23. Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China

    Xuan Zhang

  24. Departments of Rheumatology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

    Lidan Zhao

Authors
  1. Michelle Petri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Aringer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Isabelle Ayoub
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Salem Almaani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hermine Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maria Dall’Era
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mengdi Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Richard Furie
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jessica Greco
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Fiona Goldblatt
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jennifer Huggins
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. T. W. J. Huizinga
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. David Isenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Nicholas L. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. R. C. Monahan
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Samir V. Parikh
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. David Pisetsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Abin P. Puravath
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Brad Rovin
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Daniel Wallace
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Xuan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Lidan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michelle Petri .

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Harvard University Massachusetts General Hospital, Boston, MA, USA

    John H. Stone

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Petri, M. et al. (2023). Systemic Lupus Erythematosus. In: Stone, J.H. (eds) A Clinician's Pearls & Myths in Rheumatology. Springer, Cham. https://doi.org/10.1007/978-3-031-23488-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-23488-0_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-23487-3

  • Online ISBN: 978-3-031-23488-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation